Vol 44, No 3 (2010)

open access

Page views 260
Article views/downloads 325
Get Citation

Connect on Social Media

Connect on Social Media

The –A162G polymorphism of the PON1 gene and the risk of sporadic amyotrophic lateral sclerosis

Dorota Zawiślak1, Monika Ostrowska1, Aleksandra Golenia1, Monika Marona1, Barbara Tomik1, Paweł Wołkow2, Elżbieta Gryz-Kurek1, Andrzej Szczudlik1, Agnieszka Słowik1
DOI: 10.1016/S0028-3843(14)60038-4
Neurol Neurochir Pol 2010;44(3):246-250.


Background and purpose

Sporadic amyotrophic lateral sclerosis (sALS) is a devastating neurodegenerative disease, which results from complex genetic and environmental interactions. Recent studies have reported an association between several polymorphisms of the PON1 and PON2 genes and risk of sALS. The aim of the present study was to identify an association between the – A162G polymorphism of the promoter region of the human PON1 gene and the risk of sALS in a Polish population.

Material and methods

We included 259 patients with a diagnosis of definite or probable sALS (76 bulbar onset, 183 limb onset) and 694 healthy controls matched for age and sex. The diagnosis of ALS was established according to El Escorial criteria. The polymorphism was studied by Single Nucleotide Polymorphism Real-Time Polymerase Chain Reaction analysis.


No overall difference in the PONI – A162G genotype and allele distribution was seen between cases and controls (all p > 0.05). There was, however, a difference in the A allele frequency when the bulbar onset group was compared to the controls (p = 0.03), but this significance disappeared after the Bonferroni correction.


The results did not show that the – A162G polymorphism of the PON1 gene is a risk factor of sALS in a Polish population; it may affect, however, bulbar onset of the disease.

Article available in PDF format

View PDF Download PDF file

Neurologia i Neurochirurgia Polska